Skip to search formSkip to main contentSkip to account menu

cefpirome

Known as: 5H-1-Pyrindinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-5,6,7,8-tetrahydro-, hydroxide, inner salt, (6R-(6alpha,7beta(Z)))-, 3-((2,3-cyclopenteno-1-pyridinium)methyl)-7-(2-syn-methoximino-2-(2-aminothiazole-4-yl)acetamido)ceph-3-em-4-carboxylate, Cefpiroma 
A semisynthetic, broad-spectrum, fourth-generation cephalosporin with antibacterial activity. Cefpirome binds to and inactivates penicillin-binding… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2001
Highly Cited
2001
ABSTRACT Pseudomonas aeruginosa clinical isolate SOF-1 was resistant to cefepime and susceptible to ceftazidime. This resistance… 
Highly Cited
2001
Highly Cited
2001
Enterobacter cloacae CHE, a clinical strain with overproduced cephalosporinase was found to be highly resistant to the new… 
Highly Cited
1999
Highly Cited
1999
ABSTRACT While meropenem MICs were strongly influenced by the presence or absence of the MexAB-OprM efflux pump in both OprD… 
Highly Cited
1995
Highly Cited
1995
Three types of multiple-drug-resistant mutants which were phenotypically similar to previously described nalB, nfxB, and nfxC… 
Highly Cited
1994
Highly Cited
1994
The conditions for the emergence of resistance to cefpirome and ceftazidime were studied in rabbits with experimental aortic… 
Highly Cited
1993
Highly Cited
1993
The most appropriate therapy for meningitis caused by Streptococcus pneumoniae strains resistant to the extended-spectrum…